3D Bioprinting Market
Market Insights on 3D Bioprinting covering sales outlook, demand forecast & up-to-date key trends
3D Bioprinting Market by Technology (Stereolithography, Selective Laser Sintering, Electron Beam Melting, Fused Deposition Modeling), Application (Prosthetic Devices, Tissue Engineering and Regenerative Medicine), End User & Region - Forecast to 2020 - 2030
3D Bioprinting Market - About the Report
[290 Pages Report] Increasing rate of medical device manufacturing across the world has been fuelling the demand for advanced technologies. 3D bioprinting is used to design medical devices. Leading medical device and pharmaceutical manufacturing companies are focusing on improving their product portfolio across the world. The demand in this market is expected to surge in response to the lack of organ donors in adequate number. With research and development (R&D) investment within the medical devices sector poised to rise significantly, the market will gain from increasing growth opportunities in the coming years.
In its new study, ESOMAR-certified market research and consulting firm Future Market Insights (FMI) offers insights about key factors driving demand for 3D bioprinting. The report tracks the global sales of 3D bioprinting in 20+ high-growth markets, along with analyzing the impact COVID-19 has on the medical device industry in general, and 3D bioprinting in particular. COVID-19 pandemic will show a negative impact on the 3D bioprinting market. Due to short term shut down of production facilities of medical device industries for first few months in 2020
Let us know your requirement to get
100% FREE customization
How Historical and Future Outlook of 3D Bioprinting Market Match Up?
Growing aging population across the world is expected to drive the demand for orthopedic implants, as the risk of peripheral vascular disease, diabetes-related gangrene cases, and osteoarthritis is higher among elderly individuals.
According to the World Health Organization (WHO), the global ageing population is increasing rapidly. Between 2000 and 2050, the geriatric population is expected to account for 11% to 22% of the overall world population, growing from 605 million to 2 billion over the same period.
On an average, 82% of amputations are due to peripheral vascular diseases and diabetes. Over 65% of amputations, globally, are performed on people aged 50 years and older. The increasing ageing population is expected to boost the revenue growth of the 3D bioprinting market over the forecast period. According to FMI’s analysis, 3D bioprinting sales have grown at 10.8% CAGR between 2015 and 2019.
In past few years, 3D bioprinting technology has been increasingly preferred by surgeons and patients to precisely perform and plan reconstructive surgery. Therefore, key producers of 3D bioprinting are now increasing their product portfolio with the launch of 3D printers and devices as part of their extensive manufacturing strategy, which is expected to provide opportunities for market growth in the near future.
For instance, in February 2021, Advanced Solutions announced its newest patented cGMP and UL certified bioprinter, the BioAssemblyBot® 200. It uses a four-axis robotic arm to bioprint and automate the science workflow. Moreover, Major medical device manufacturer highly rely on 3D bioprinters to manufacture medical devices such as orthopedic implants. These developments present a positive outlook for growth. FMI expects global 3D bioprinting market to grow at 12.9%CAGR through 2030.
How is 3D Bioprinting a Potential Solution for Organ Transplant?
3D bioprinting method is an alternative to overcome existing organ ongoing organ donation shortage crisis worldwide, if 3D bioprinters were capable to print out any human organ. For instance, according to the U.S. Government Information on Organ Donation and Transplantation, more than 113,000 people are on the waiting list for national organ transplant as of July 2019. Unavailability of organs for transplant cause death of 20 patients per day.
Researchers are trying to develop cardiac tissue with tissue engineering in the patch form, which is implanted directly onto scar tissue. With the help of engineered cardiac tissue, researchers try to decrease the need for organ transplants, prevent subsequent events, and improve recovery. For instance, in June 2019, Imperial College London creates thumb-size patches of heart tissue which can mimic the tissue of mature heart within 30 days and it start beat continuously after three days. These patches successfully led to improvements in heart function following a heart attack after only four weeks.
3D bioprinting can be a significant solution to the organ transplant waiting crisis so that patients can receive organ for transplant in time.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWhy is 3D Bioprinting Considered the New Frontier in Regenerative Healthcare?
3D bioprinting technology has been used in regenerative medicine with the help 3D printed devices such as surgical instruments and prosthetics. Currently researchers are testing out bio-ink as a way of printing cartilage, bones, and vital organs.
Ongoing research on regenerative medicine and advancements in tissue engineering are being aimed at regeneration of damaged tissues and organs with the help of 3D bioprinting. For instance, a scientists group from Tel Aviv University developed fully vascularized heart with the help 3D bioprinting by using fat tissue cells from a donor. Scientist from Swansea University UK has developed a 3D bioprinting process by using regenerative and durable biomaterial and generate an artificial bone matrix.
The Christchurch Regenerative Medicine and Tissue Engineering (CReATE) Group, a multidisciplinary research team in New Zealand, is focusing on developing innovative bio printing techniques and biomaterials using 3D bioprinting technology in order to repair damaged tissue following trauma or a disease.
The key component of the 3D bioprinting is bioink, which is important for the development of tissue structures and functional organs. Currently, inkjet bioprinting and direct ink writing are frequently preferred for 3D bioprinting of live cells.
What is the Role of 3D Bioprinting in Advanced Dermatology?
Burns and scars particularly on exposed parts of the body can adversely affect the appearance and in turn consciousness and self-confidence of an individual. Increasing number of dermal procedures and treatments across the globe is driven due to growing consumer awareness about personal appearance and increasing personal disposable income.
According to the U.S.-based National Institute of Aging and American Academy of Plastic Surgeons, in the U.S a remarkable share of the population, mostly between the age group between 16-33, is adapting advanced dermatology, dental services, thus creating sufficient traction for product manufacturers. Growing awareness about self-care is among the major factors driving growth of the 3D bioprinting market in developed regions such as North America and Europe, as 3D bioprinting in healthcare assists in bio printing of skin tissues.
An unified Market Research Subscription Platform, built for today’s disparate research needs.
What Is the Impact of Intellectual Property, Ethical Considerations On 3D Bioprinting Market?
Ethical, religious, and moral questions are expected to be raised about human nature of manipulating own selection process by synthetically manufacturing human body organs with the help of 3D bioprinting.
As per experts, evolution of 3D bioprinting is associated with intellectual property theft and is expected to create major challenges in the future resulting in loss of approximately US$ 100,000 Mn per year in IP, globally. For distribution of 3D printed version of a patented product, one needs to negotiate a license with patent owner or else the distribution process would considered to be violating the patent laws.
Currently, many researchers are not only trying to print non-human cells through 3D bioprinting but are also trying to merge human cells with non-human cells, which is expected to raise ethical issues over the coming years.
What’s the Impact of 3D Bioprinting on Surgical Practice?
Medical models have revolutionized surgeries and are assisting surgeons across the globe to reduce time and complexity involved in completion of a surgical procedure. Although applications of 3D-printing in the operating room is restricted to certain procedures as of now, surgeons can design their procedure in advance to reduced time and error of surgery. Surgical procedures are becoming faster, cheaper, and less dangerous resulting in cost and time saving, which means more number of surgical procedures can be performed annually.
Surgeons can study CT scan data of a patient’s blood vessels, complex surgery, bone or other organs by converting it into a digital file with the help of 3D-printing, which can be studied and manipulated. Through printed custom tools and guides, 3D bioprinting is useful for surgeries involving drilling and cutting such as joint replacement surgeries. Over the next decade, it is most likely that custom surgical guides and medical models manufactured by 3D-printing will be a standard procedure for diverse surgical procedures such as cranial implants, joint replacement, cardiac surgeries, and spinal surgeries.
What are the limitation of 3D Bioprinting?
Only certain materials such as resins, plastics, and few of metals are used for 3D bioprinting. Consumption of other materials for 3D bioprinting increases the operational cost and is time consuming. Also, the size of the printer limits the size of the product and thus, it is quiet challenging job to manufacture parts of large industrial machines.
Apart from this, there are few more limitations such as difficulty in achieving tight manufacturing tolerances and as compared to conventional subtractive manufacturing processes, the speed of production is relatively slow. Biocompatibility of materials used for manufacturing 3D Bioprinting is also a major concern when creating implantable devices or tissues to avoid allergic reactions. Also, high costs and low availability of 3D printers in various regions is a concern for the revenue growth of the 3D bioprinting market.
3D Bioprinting Market - Country-wise Insights
How Government Initiatives is Impacting China 3D bioprinting Market?
In order to accelerate innovation in 3D bioprinting technology, government and non-profit organizations are collaborating resources and coordinating standards in order to drive rapid growth of the industry.
Chinese government is providing funding for the establishment of manufacturing facility for production of biomaterials and studying 3D printed organs and tissues. In 2015, Materialise NV. opened its first pediatric 3D medical research facility at the Children’s Medical Center, Shanghai, China, with the focus on pediatric 3D modelling and medical imaging and 3D fabrication.
Also, in July 2016, Hkable Biological 3D and the local government of Fengdu county, collaborated to build first 3D bioprinting factory for medical products. The Chinese government has invested US$ 7.5 million on this new facility and started commence operations in early 2017
What is the impact of FDA Approvals on the U.S 3D Bioprinting Market?
Manufacturing method of 3D bioprinting is different than that of conventional medical devices, thus they might require different and additional forms of testing. However, currently the Food & Drug Administration (FDA) treats 3D Bioprinting same as medical devices made conventionally.
To receive FDA approval, the new device must undergo process of attaining premarket approval or its manufacturers must ascertain that new device corresponds to one already being marketed for the identical use. Key players in the market are getting approvals for 3D bioprinting which further help to increase revenue of the 3D bioprinting market
Geriatric Population Influencing 3D bioprinting Market in Japan
Growing aging population across the world is expected to drive the demand for orthopedic implants, as the risk of osteoarthritis, diabetes-related gangrene cases, and peripheral vascular disease is higher among elderly individuals. Increasing ageing population is expected to boost the revenue growth of the 3D bioprinting market over the forecast period.
According to United Nations Population Division, World Population Prospects 2019 data, Japan has 28.2% geriatric population. Moreover significant research on 3D bioprinting also fuel the growth of the market. For instance, in 2019 Ricoh, a leading Japanese company release human cell-infused chips by spring. Ricoh operates its proprietary 3D bioprinter in Tokyo
How Are 3D Bioprinting Startups Enabling Growth In Germany?
3D bioprinting market growth in Germany is expected to happen at an accelerated pace. As per the FMI analysis, presence of new startup Companies in Germany is more. Companies such as Mecuris, Fluicell, BigRep. Moreover, key players such as Electro Optical Systems, EnvisionTEC, GeSiM, 3D Systems, Inc present in Germany which creates significant revenue which create surge in 3D Bioprinting production in Germany.
3D Bioprinting Market - Category-wise Insights
Which is More Preferred 3D Bioprinting Technology?
The fused deposition modeling (FDM) technology is forecast by FMI to remain dominant through the forecast period. However, the inkjet-based segment is expected to exhibit growth at a much higher pace. The technology helps in printing of complex living organs and tissues. The segment is forecast to rise at above 14% CAGR through the forecast period.
Which is the Key Application for 3D Bioprinting?
3D bioprinting application is expected to be the highest in case of manufacturing orthopedic implants. According to the World Health Organization (WHO), nearly 1.71 billion have musculoskeletal conditions around the world. With the prevalence showing no signs of slowing down, focus on 3D bioprinting for orthopedic implants is expected to surge in the coming years.
Who is the Leading 3D Bioprinting End User?
Medical device manufacturers exhibit significantly high demand for 3D bioprinting. Rising demand for implants for administering effecting treatment is one of the key factors aiding the expansion of the segment. FMI has forecast it to account for over 45% of the overall market through the forecast period.
Competitive Landscape
The global market is dominated by top manufacturers- 3D Systems, Inc, GE Healthcare, Electro Optical Systems, Stratasys Ltd, Renishaw plc. Major Manufacturers are focusing on development of intermediates by offering wide range of 3D bioprinting. Moreover, Major players in 3D bioprinting market focus on enhancing their global and regional presence through acquisition and expansion. For instance, On February 2019, In January 2021, 3D Systems announced its regenerative and bioprinting solutions expansion by actively investing in the regenerative areas, in collaboration with United Therapeutics Corporation. In February 2021, TCL Hoffmann signed an exclusive distribution agreement with ExOne as a channel partner, to sell the ExOnes’s industrial solutions and technology to Australia and New Zealand. This agreement expects to strengthen the ExOne’s network sales outreach in the key Asian markets
Some of the leading companies operating in the market are:
- 3D Systems, Inc
- GE Healthcare
- ExOne (S. Kent Rockwell]
- Electro Optical Systems
- Renishaw plc.
- Stratasys Ltd.
- EnvisionTEC
- Cyfuse Biomedical K.K.
- Formlabs, Inc.
- Organovo Holdings Inc,
- Allevi Inc.
- Advanced Solutions Life Sciences, LLC
- Aspect Biosystems
- CELLINK
- GeSiM
- Bio3D Technologies Pte. Ltd.
- Regenovo Biotechnology Co. Ltd.
- Optomec Inc.
*The list is not exhaustive, and only for representational purposes. Full competitive intelligence analysis available in the report.
3D Bioprinting Market - Scope of the Report
|
Attribute |
Details |
|
Forecast Period |
2020-2030 |
|
Historical Data Available for |
2016-2020 |
|
Market Analysis |
USD Million for value and Units for Volume |
|
Key Regions Covered |
North America, Latin America, Europe, East Asia, South Asia, Oceania Middle East & Africa |
|
Key Countries Covered |
US, Canada, Germany, U.K., France, Italy, Spain, BENELUX, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, Turkey, Northern Africa, South Africa |
|
Key Segments Covered |
Technology, Application, End User and Region |
|
Key Companies Profiled |
|
|
Report Coverage |
Market Forecast, company share analysis, competition intelligence, DROT analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
|
Customization & Pricing |
3D bioprinting Market by Category
Technology
- Stereolithography (SLA)
- Selective Laser Sintering
- Electron Beam Melting
- Fused Deposition Modeling (FDM)
- Laminated Object Manufacturing (LOM
- Inkjet Printing
- Multi-phase Jet Solidification
Application
- Surgical Simulation and Training Models
- Prosthetic Devices
- Tissue Engineering and Regenerative Medicine
- Orthopedic Implants
- Dental Implants
- Medical Sensors
- Others
End User
- Medical Device Manufacturers
- Pharmaceutical Companies
- Research & Academic Institutions
- Contract Research Organizations
Region
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Middle East and Africa (MEA)
- Oceania
Frequently Asked Questions
The U.S currently leads the global market for 3D bioprinting. Sales in U.S will be over 36% of total demand throughout the forecast period.
Fused Deposition Modeling (FDM) are highly sought-after in every market. The demand for Fused Deposition Modeling (FDM) technology is expected to remain high in the near future, especially due to growing usage in medical device 3D bioprinting.
There are ethical problems involved in 3D bioprinting as in many other aspects of Bioengineering. These could pose challenges to the market.
Some of the leading companies offering 3D bioprinting are GE Healthcare, 3D Systems, Inc, Electro Optical Systems, Stratasys Ltd, Renishaw plc, among others.
The World Health Organization has identified prevalence of orthopedic conditions ranges from 7.2% to 36.2% globally. The rising incidence of orthopedic around the world is fuelling the demand for 3D bioprinting for producing orthopaedic implants.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Technology Roadmap
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Key Success Factors
4.1. Product Adoption / Usage Analysis
4.2. Strategic Promotional Strategies
4.3. Regulatory Scenario
5. COVID-19 Crisis Analysis
5.1. Current COVID19 Statistics and Probable Future Impact
5.2. Current GDP Projection and Probable Impact
5.3. Current Economic Projection as compared to 2008 Economic analysis
5.4. COVID19 and Impact Analysis, by Country
5.5. 2020 Market Scenario
5.6. Recovery Scenario – Short term, Midterm and Long Term Impact
6. Global 3D Bioprinting Market Demand Analysis 2015-2019 and Forecast, 2020-2030
6.1. Historical Market Volume (Units) Analysis, 2015-2019
6.2. Current and Future Market Volume (Units) Projections, 2020-2030
6.3. Y-o-Y Growth Trend Analysis
7. Global 3D Bioprinting Market - Pricing Analysis
7.1. Regional Pricing Analysis By Technology Type
7.2. Pricing Break-up
7.2.1. Manufacturer Level Pricing
7.2.2. Distributor Level Pricing
7.3. Global Average Pricing Analysis Benchmark
8. Global 3D Bioprinting Market Demand (in Value or Size in US$ Mn) Analysis 2015-2020 and Forecast, 2020-2030
8.1. Historical Market Value (US$ Mn) Analysis, 2015-2020
8.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030
8.2.1. Y-o-Y Growth Trend Analysis
8.2.2. Absolute $ Opportunity Analysis
9. Market Background
9.1. Macro-Economic Factors
9.1.1. Global GDP Growth Outlook
9.1.2. Global Healthcare Outlook
9.1.3. Income Per Capita Outlook
9.2. Forecast Factors - Relevance & Impact
9.2.1. Growing Usage of 3D Printing in Cosmetic Surgeries
9.2.2. Rising Cases of Chronic Diseases
9.2.3. Rising Funding in Medical Application for Drug Development
9.2.4. Innovation in the 3D Bioprinting
9.2.5. Governmental and Non-governmental Support In Medical Supplies
9.3. Market Dynamics
9.3.1. Drivers
9.3.2. Restraints
9.3.3. Opportunity Analysis
10. Global 3D Bioprinting Market Analysis 2015–2019 and Forecast 2020-2030, by Technology
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By Technology, 2015–2020
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Technology, 2020-2030
10.3.1. Stereolithography (SLA)
10.3.2. Selective Laser Sintering
10.3.3. Electron Beam Melting
10.3.4. Fused Deposition Modelling (FDM)
10.3.5. Laminated Object Manufacturing (LOM)
10.3.6. Inkjet Printing
10.3.7. Multi-phase Jet Solidification
10.4. Market Attractiveness Analysis By Technology
11. Global 3D Bioprinting Market Analysis 2015–2019 and Forecast 2020-2030, by Application
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis By Application, 2015–2020
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2020-2030
11.3.1. Surgical Simulation and Training Models
11.3.2. Prosthetic Devices
11.3.3. Tissue Engineering and Regenerative Medicine
11.3.4. Orthopedic Implants
11.3.5. Dental Implants
11.3.6. Medical Sensors
11.3.7. Other
11.4. Market Attractiveness Analysis By Application
12. Global 3D Bioprinting Market Analysis 2015–2019 and Forecast 2020-2030, by End User
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Mn) Analysis By End User, 2015–2020
12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2020-2030
12.3.1. Medical Device Manufacturers
12.3.2. Pharmaceutical Companies
12.3.3. Research & Academic Institutions
12.3.4. Contract Research Organization
12.4. Market Attractiveness Analysis By End User
13. Global 3D Bioprinting Market Analysis 2015–2019 and Forecast 2020-2030, by Region
13.1. Introduction / Key Findings
13.2. Historical Market Size (US$ Mn) Analysis By Region, 2015–2020
13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2020-2030
13.3.1. North America
13.3.2. Latin America
13.3.3. Europe
13.3.4. East Asia
13.3.5. South Asia
13.3.6. Oceania
13.3.7. Middle East and Africa (MEA)
13.4. Market Attractiveness Analysis By Region
14. North America 3D Bioprinting Market Analysis 2015–2019 and Forecast 2020-2030
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2020
14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030
14.3.1. By Country
14.3.1.1. U.S.
14.3.1.2. Canada
14.3.2. By Technology
14.3.3. By Application
14.3.4. By End User
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Technology
14.4.3. By Application
14.4.4. By End User
14.5. Market Trends
14.6. Key Market Participants - Intensity Mapping
14.7. Drivers and Restraints - Impact Analysis
15. Latin America 3D Bioprinting Market Analysis 2015–2019 and Forecast 2020-2030
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2020
15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030
15.3.1. By Country
15.3.1.1. Brazil
15.3.1.2. Mexico
15.3.1.3. Rest of Latin America
15.3.2. By Technology
15.3.3. By Application
15.3.4. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Technology
15.4.3. By Application
15.4.4. By End User
15.5. Key Market Participants - Intensity Mapping
15.6. Drivers and Restraints - Impact Analysis
16. Europe 3D Bioprinting Market Analysis 2015–2019 and Forecast 2020-2030
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2020
16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030
16.3.1. By Country
16.3.1.1. Germany
16.3.1.2. Italy
16.3.1.3. France
16.3.1.4. U.K.
16.3.1.5. Spain
16.3.1.6. BENELUX
16.3.1.7. Russia
16.3.1.8. Rest of Europe
16.3.2. By Technology
16.3.3. By Application
16.3.4. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Technology
16.4.3. By Application
16.4.4. By End User
16.5. Key Market Participants - Intensity Mapping
16.6. Drivers and Restraints - Impact Analysis
17. South Asia 3D Bioprinting Market Analysis 2015–2019 and Forecast 2020-2030
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2020
17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030
17.3.1. By Country
17.3.1.1. India
17.3.1.2. Thailand
17.3.1.3. Indonesia
17.3.1.4. Malaysia
17.3.1.5. Rest of South Asia
17.3.2. By Technology
17.3.3. By Application
17.3.4. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Technology
17.4.3. By Application
17.4.4. By End User
17.5. Key Market Participants - Intensity Mapping
17.6. Drivers and Restraints - Impact Analysis
18. East Asia 3D Bioprinting Market Analysis 2015–2019 and Forecast 2020-2030
18.1. Introduction
18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2020
18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030
18.3.1. By Country
18.3.1.1. China
18.3.1.2. Japan
18.3.1.3. South Korea
18.3.2. By Technology
18.3.3. By Application
18.3.4. By End User
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Technology
18.4.3. By Application
18.4.4. By End User
18.5. Key Market Participants - Intensity Mapping
18.6. Drivers and Restraints - Impact Analysis
19. Oceania 3D Bioprinting Market Analysis 2015–2019 and Forecast 2020-2030
19.1. Introduction
19.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2020
19.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030
19.3.1. By Country
19.3.1.1. Australia
19.3.1.2. New Zealand
19.3.2. By Technology
19.3.3. By Application
19.3.4. By End User
19.4. Market Attractiveness Analysis
19.4.1. By Country
19.4.2. By Technology
19.4.3. By Application
19.4.4. By End User
19.5. Key Market Participants - Intensity Mapping
19.6. Drivers and Restraints - Impact Analysis
20. Middle East and Africa 3D Bioprinting Market Analysis 2015–2019 and Forecast 2020-2030
20.1. Introduction
20.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2020
20.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030
20.3.1. By Country
20.3.1.1. GCC Countries
20.3.1.2. Turkey
20.3.1.3. Northern Africa
20.3.1.4. South Africa
20.3.1.5. Rest of Middle East and Africa
20.3.2. By Technology
20.3.3. By Application
20.3.4. By End User
20.4. Market Attractiveness Analysis
20.4.1. By Country
20.4.2. By Technology
20.4.3. By Application
20.4.4. By End User
20.5. Key Market Participants - Intensity Mapping
20.6. Drivers and Restraints - Impact Analysis
21. Key & Emerging Countries 3D Bioprinting Market Analysis 2015–2019 and Forecast 2020–2030
21.1. U.S. 3D Bioprinting Market Analysis
21.1.1. By Technology
21.1.2. By Application
21.1.3. By End User
21.2. Canada 3D Bioprinting Market Analysis
21.2.1. By Technology
21.2.2. By Application
21.2.3. By End User
21.3. Brazil 3D Bioprinting Market Analysis
21.3.1. By Technology
21.3.2. By Application
21.3.3. By End User
21.4. Mexico 3D Bioprinting Market Analysis
21.4.1. By Technology
21.4.2. By Application
21.4.3. By End User
21.5. U.K. 3D Bioprinting Market Analysis
21.5.1. By Technology
21.5.2. By Application
21.5.3. By End User
21.6. Germany 3D Bioprinting Market Analysis
21.6.1. By Technology
21.6.2. By Application
21.6.3. By End User
21.7. France 3D Bioprinting Market Analysis
21.7.1. By Technology
21.7.2. By Application
21.7.3. By End User
21.8. Italy 3D Bioprinting Market Analysis
21.8.1. By Technology
21.8.2. By Application
21.8.3. By End User
21.9. Spain 3D Bioprinting Market Analysis
21.9.1. By Technology
21.9.2. By Application
21.9.3. By End User
21.10. Russia 3D Bioprinting Market Analysis
21.10.1. By Technology
21.10.2. By Application
21.10.3. By End User
21.11. India 3D Bioprinting Market Analysis
21.11.1. By Technology
21.11.2. By Application
21.11.3. By End User
21.12. Indonesia 3D Bioprinting Market Analysis
21.12.1. By Technology
21.12.2. By Application
21.12.3. By End User
21.13. China 3D Bioprinting Market Analysis
21.13.1. By Technology
21.13.2. By Application
21.13.3. By End User
21.14. Japan 3D Bioprinting Market Analysis
21.14.1. By Technology
21.14.2. By Application
21.14.3. By End User
21.15. South Korea 3D Bioprinting Market Analysis
21.15.1. By Technology
21.15.2. By Application
21.15.3. By End User
21.16. Australia 3D Bioprinting Market Analysis
21.16.1. By Technology
21.16.2. By Application
21.16.3. By End User
21.17. New Zealand 3D Bioprinting Market Analysis
21.17.1. By Technology
21.17.2. By Application
21.17.3. By End User
21.18. GCC Countries 3D Bioprinting Market Analysis
21.18.1. By Technology
21.18.2. By Application
21.18.3. By End User
21.19. South Africa 3D Bioprinting Market Analysis
21.19.1. By Technology
21.19.2. By Application
21.19.3. By End User
21.20. Turkey 3D Bioprinting Market Analysis
21.20.1. By Technology
21.20.2. By Application
21.20.3. By End User
22. Market Structure Analysis
22.1. Market Analysis by Tier of Companies (3D Bioprinting)
22.2. Market Share Analysis of Top Players
22.3. Market Presence Analysis
22.3.1. By Regional footprint of Players
22.3.2. Product foot print by Players
22.3.3. Channel Foot Print by Players
23. Competition Analysis
23.1. Competition Dashboard
23.2. Competition Benchmarking
23.3. Competition Deep Dive
23.3.1. 3D Systems, Inc.
23.3.1.1. Overview
23.3.1.2. Product Portfolio
23.3.1.3. Profitability by Market Segments (Product/Channel/Region)
23.3.1.4. Sales Footprint
23.3.1.5. Strategy Overview
23.3.1.5.1. Marketing Strategy
23.3.1.5.2. Product Strategy
23.3.1.5.3. Channel Strategy
23.3.2. GE Healthcare (Concept Laser, Arcam AB)
23.3.2.1. Overview
23.3.2.2. Product Portfolio
23.3.2.3. Profitability by Market Segments (Product/Channel/Region)
23.3.2.4. Sales Footprint
23.3.2.5. Strategy Overview
23.3.2.5.1. Marketing Strategy
23.3.2.5.2. Product Strategy
23.3.2.5.3. Channel Strategy
23.3.3. EOS GmbH Electro Optical Systems
23.3.3.1. Overview
23.3.3.2. Product Portfolio
23.3.3.3. Profitability by Market Segments (Product/Channel/Region)
23.3.3.4. Sales Footprint
23.3.3.5. Strategy Overview
23.3.3.5.1. Marketing Strategy
23.3.3.5.2. Product Strategy
23.3.3.5.3. Channel Strategy
23.3.4. Renishaw plc.
23.3.4.1. Overview
23.3.4.2. Product Portfolio
23.3.4.3. Profitability by Market Segments (Product/Channel/Region)
23.3.4.4. Sales Footprint
23.3.4.5. Strategy Overview
23.3.4.5.1. Marketing Strategy
23.3.4.5.2. Product Strategy
23.3.4.5.3. Channel Strategy
23.3.5. ExOne (S. Kent Rockwell]
23.3.5.1. Overview
23.3.5.2. Product Portfolio
23.3.5.3. Profitability by Market Segments (Product/Channel/Region)
23.3.5.4. Sales Footprint
23.3.5.5. Strategy Overview
23.3.5.5.1. Marketing Strategy
23.3.5.5.2. Product Strategy
23.3.5.5.3. Channel Strategy
23.3.6. Stratasys Ltd.
23.3.6.1. Overview
23.3.6.2. Product Portfolio
23.3.6.3. Profitability by Market Segments (Product/Channel/Region)
23.3.6.4. Sales Footprint
23.3.6.5. Strategy Overview
23.3.6.5.1. Marketing Strategy
23.3.6.5.2. Product Strategy
23.3.6.5.3. Channel Strategy
23.3.7. EnvisionTEC
23.3.7.1. Overview
23.3.7.2. Product Portfolio
23.3.7.3. Profitability by Market Segments (Product/Channel/Region)
23.3.7.4. Sales Footprint
23.3.7.5. Strategy Overview
23.3.7.5.1. Marketing Strategy
23.3.7.5.2. Product Strategy
23.3.7.5.3. Channel Strategy
23.3.8. Cyfuse Biomedical K.K.
23.3.8.1. Overview
23.3.8.2. Product Portfolio
23.3.8.3. Profitability by Market Segments (Product/Channel/Region)
23.3.8.4. Sales Footprint
23.3.8.5. Strategy Overview
23.3.8.5.1. Marketing Strategy
23.3.8.5.2. Product Strategy
23.3.8.5.3. Channel Strategy
23.3.9. Formlabs, Inc.
23.3.9.1. Overview
23.3.9.2. Product Portfolio
23.3.9.3. Profitability by Market Segments (Product/Channel/Region)
23.3.9.4. Sales Footprint
23.3.9.5. Strategy Overview
23.3.9.5.1. Marketing Strategy
23.3.9.5.2. Product Strategy
23.3.9.5.3. Channel Strategy
23.3.10. Organovo Holdings Inc,
23.3.10.1. Overview
23.3.10.2. Product Portfolio
23.3.10.3. Profitability by Market Segments (Product/Channel/Region)
23.3.10.4. Sales Footprint
23.3.10.5. Strategy Overview
23.3.10.5.1. Marketing Strategy
23.3.10.5.2. Product Strategy
23.3.10.5.3. Channel Strategy
23.3.11. Allevi Inc.
23.3.11.1. Overview
23.3.11.2. Product Portfolio
23.3.11.3. Profitability by Market Segments (Product/Channel/Region)
23.3.11.4. Sales Footprint
23.3.11.5. Strategy Overview
23.3.11.5.1. Marketing Strategy
23.3.11.5.2. Product Strategy
23.3.11.5.3. Channel Strategy
23.3.12. Advanced Solutions Life Sciences, LLC (BioBots)
23.3.12.1. Overview
23.3.12.2. Product Portfolio
23.3.12.3. Profitability by Market Segments (Product/Channel/Region)
23.3.12.4. Sales Footprint
23.3.12.5. Strategy Overview
23.3.12.5.1. Marketing Strategy
23.3.12.5.2. Product Strategy
23.3.12.5.3. Channel Strategy
23.3.13. Aspect Biosystems
23.3.13.1. Overview
23.3.13.2. Product Portfolio
23.3.13.3. Profitability by Market Segments (Product/Channel/Region)
23.3.13.4. Sales Footprint
23.3.13.5. Strategy Overview
23.3.13.5.1. Marketing Strategy
23.3.13.5.2. Product Strategy
23.3.13.5.3. Channel Strategy
23.3.14. CELLINK
23.3.14.1. Overview
23.3.14.2. Product Portfolio
23.3.14.3. Profitability by Market Segments (Product/Channel/Region)
23.3.14.4. Sales Footprint
23.3.14.5. Strategy Overview
23.3.14.5.1. Marketing Strategy
23.3.14.5.2. Product Strategy
23.3.14.5.3. Channel Strategy
23.3.15. GeSiM
23.3.15.1. Overview
23.3.15.2. Product Portfolio
23.3.15.3. Profitability by Market Segments (Product/Channel/Region)
23.3.15.4. Sales Footprint
23.3.15.5. Strategy Overview
23.3.15.5.1. Marketing Strategy
23.3.15.5.2. Product Strategy
23.3.15.5.3. Channel Strategy
23.3.16. Bio3D Technologies Pte. Ltd.
23.3.16.1. Overview
23.3.16.2. Product Portfolio
23.3.16.3. Profitability by Market Segments (Product/Channel/Region)
23.3.16.4. Sales Footprint
23.3.16.5. Strategy Overview
23.3.16.5.1. Marketing Strategy
23.3.16.5.2. Product Strategy
23.3.16.5.3. Channel Strategy
23.3.17. Optomec Inc.
23.3.17.1. Overview
23.3.17.2. Product Portfolio
23.3.17.3. Profitability by Market Segments (Product/Channel/Region)
23.3.17.4. Sales Footprint
23.3.17.5. Strategy Overview
23.3.17.5.1. Marketing Strategy
23.3.17.5.2. Product Strategy
23.3.17.5.3. Channel Strategy
24. Assumptions and Acronyms Used
25. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01: Global 3D Bioprinting Market Demand (in Volume 000'Units) Analysis- and Opportunity Assessment 2015–2030, By Technology
Table 02: Global 3D Bioprinting Market Value (US$ Mn) Analysis- and Opportunity Assessment 2015–2030, By Technology
Table 03: Global 3D Bioprinting Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Application
Table 04: Global 3D Bioprinting Market Value (US$ Mn) Analysis- and Opportunity Assessment 2015–2030, By End User
Table 05: Global 3D Bioprinting Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Region
Table 06: North America 3D Bioprinting Market Demand (in Volume 000'Units) Analysis 2015-2019 and Forecast 2020–2030, By Technology
Table 07: North America 3D Bioprinting Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Technology
Table 08: North America 3D Bioprinting Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Application
Table 09: North America 3D Bioprinting Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By End User
Table 10: North America 3D Bioprinting Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Country
Table 11: Latin America 3D Bioprinting Market Demand (in Volume 000'Units) Analysis 2015-2019 and Forecast 2020–2030, By Technology
Table 12: Latin America 3D Bioprinting Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Technology
Table 13: Latin America 3D Bioprinting Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Application
Table 14: Latin America 3D Bioprinting Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By End User
Table 15: Latin America 3D Bioprinting Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Country
Table 16: Europe 3D Bioprinting Market Demand (in Volume 000'Units) Analysis 2015-2019 and Forecast 2020–2030, By Technology
Table 17: Europe 3D Bioprinting Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Technology
Table 18: Europe 3D Bioprinting Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Application
Table 19: Europe 3D Bioprinting Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By End User
Table 20: Europe 3D Bioprinting Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Country
Table 21: South Asia 3D Bioprinting Market Demand (in Volume 000'Units) Analysis 2015-2019 and Forecast 2020–2030, By Technology
Table 22: South Asia 3D Bioprinting Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Technology
Table 23: South Asia 3D Bioprinting Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Application
Table 24: South Asia 3D Bioprinting Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By End User
Table 25: South Asia 3D Bioprinting Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Country
Table 26: East Asia 3D Bioprinting Market Demand (in Volume 000'Units) Analysis 2015-2019 and Forecast 2020–2030, By Technology
Table 27: East Asia 3D Bioprinting Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Technology
Table 28: East Asia 3D Bioprinting Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Application
Table 29: East Asia 3D Bioprinting Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By End User
Table 30: East Asia 3D Bioprinting Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Country
Table 31: Oceania 3D Bioprinting Market Demand (in Volume 000'Units) Analysis 2015-2019 and Forecast 2020–2030, By Technology
Table 32: Oceania 3D Bioprinting Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Technology
Table 33: Oceania 3D Bioprinting Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Application
Table 34: Oceania 3D Bioprinting Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By End User
Table 35: Oceania 3D Bioprinting Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Country
Table 36: Middle East and Africa 3D Bioprinting Market Demand (in Volume 000'Units) Analysis 2015-2019 and Forecast 2020–2030, By Technology
Table 37: Middle East and Africa 3D Bioprinting Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Technology
Table 38: Middle East and Africa 3D Bioprinting Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Application
Table 39: Middle East and Africa 3D Bioprinting Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By End User
Table 40: Middle East and Africa 3D Bioprinting Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Country
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 1: Global 3D Bioprinting Market Historical Market Volume Analysis, 2015-2019
Figure 2: Global 3D Bioprinting Current and Future Market Volume, 2020-2030 & Y-o-Y Growth Trend Analysis
Figure 03: Global 3D Bioprinting Market Value Analysis (US$ Mn), 2015-2019
Figure 04: Global 3D Bioprinting Market Value Forecast (US$ Mn), 2020-2030 & Y-o-Y Growth (%), 2020-2030
Figure 05: Global 3D Bioprinting Market Absolute $ Opportunity, 2020-2030
Figure 06: Global 3D Bioprinting Market Share Analysis (%), By Technology, 2020 & 2030
Figure 07: Global 3D Bioprinting Market Y-o-Y Analysis (%), By Technology, 2020-2030
Figure 08: Global 3D Bioprinting Market Attractiveness Analysis By Technology, 2020-2030
Figure 09: Global 3D Bioprinting Market Share Analysis (%), By Application, 2020 & 2030
Figure 10: Global 3D Bioprinting Market Y-o-Y Analysis (%), By Application, 2020-2030
Figure 11: Global 3D Bioprinting Market Attractiveness Analysis By Application, 2020-2030
Figure 12: Global 3D Bioprinting Market Share Analysis (%), By End User, 2020 & 2030
Figure 13: Global 3D Bioprinting Market Y-o-Y Analysis (%), By End User, 2020-2030
Figure 14: Global 3D Bioprinting Market Attractiveness Analysis By End User, 2020-2030
Figure 15: Global 3D Bioprinting Market Share Analysis (%), By Region, 2020 & 2030
Figure 16: Global 3D Bioprinting Market Y-o-Y Analysis (%), By Region, 2020-2030
Figure 17: Global 3D Bioprinting Market Attractiveness Analysis by Region, 2020-2030
Figure 18: North America 3D Bioprinting Market Value Analysis (US$ Mn), 2015-2019
Figure 19: North America 3D Bioprinting Market Value Forecast (US$ Mn), 2020-2030 & Y-o-Y Growth (%), 2020-2030
Figure 20: North America 3D Bioprinting Market Share, By Technology (2020)
Figure 21: North America 3D Bioprinting Market Share, By End User (2020)
Figure 22: North America 3D Bioprinting Market Share, By Application (2020)
Figure 23: North America 3D Bioprinting Market Share, By Country (2020)
Figure 24: North America 3D Bioprinting Market Attractiveness Analysis By Technology, 2020-2030
Figure 25: North America 3D Bioprinting Market Attractiveness Analysis By Application, 2020-2030
Figure 26: North America 3D Bioprinting Market Attractiveness Analysis By End User, 2020-2030
Figure 27: North America 3D Bioprinting Market Attractiveness Analysis By Country, 2020-2030
Figure 28: Latin America 3D Bioprinting Market Value Analysis (US$ Mn), 2015-2019
Figure 29: Latin America 3D Bioprinting Market Value Forecast (US$ Mn), 2020-2030 & Y-o-Y Growth (%), 2020-2030
Figure 30: Latin America 3D Bioprinting Market Share, By Technology (2020)
Figure 31: Latin America 3D Bioprinting Market Share, By End User (2020)
Figure 32: Latin America 3D Bioprinting Market Share, By Application (2020)
Figure 33: Latin America 3D Bioprinting Market Share, By Country (2020)
Figure 34: Latin America 3D Bioprinting Market Attractiveness Analysis By Technology, 2020-2030
Figure 35: Latin America 3D Bioprinting Market Attractiveness Analysis By Application, 2020-2030
Figure 36: Latin America 3D Bioprinting Market Attractiveness Analysis By End User, 2020-2030
Figure 37: Latin America 3D Bioprinting Market Attractiveness Analysis By Country, 2020-2030
Figure 38: Europe 3D Bioprinting Market Value Analysis (US$ Mn), 2015-2019
Figure 39: Europe 3D Bioprinting Market Value Forecast (US$ Mn), 2020-2030 & Y-o-Y Growth (%), 2020-2030
Figure 40: Europe 3D Bioprinting Market Share, By Technology (2020)
Figure 41: Europe 3D Bioprinting Market Share, By End User (2020)
Figure 42: Europe 3D Bioprinting Market Share, By Application (2020)
Figure 43: Europe 3D Bioprinting Market Share, By Country (2020)
Figure 44: Europe 3D Bioprinting Market Attractiveness Analysis By Technology, 2020-2030
Figure 45: Europe 3D Bioprinting Market Attractiveness Analysis By Application, 2020-2030
Figure 46: Europe 3D Bioprinting Market Attractiveness Analysis By End User, 2020-2030
Figure 47: Europe 3D Bioprinting Market Attractiveness Analysis By Country, 2020-2030
Figure 48: South Asia 3D Bioprinting Market Value Analysis (US$ Mn), 2015-2019
Figure 49: South Asia 3D Bioprinting Market Value Forecast (US$ Mn), 2020-2030 & Y-o-Y Growth (%), 2020-2030
Figure 50: South Asia 3D Bioprinting Market Share, By Technology (2020)
Figure 51: South Asia 3D Bioprinting Market Share, By End User (2020)
Figure 52: South Asia 3D Bioprinting Market Share, By Application (2020)
Figure 53: South Asia 3D Bioprinting Market Share, By Country (2020)
Figure 54: South Asia 3D Bioprinting Market Attractiveness Analysis By Technology, 2020-2030
Figure 55: South Asia 3D Bioprinting Market Attractiveness Analysis By Application, 2020-2030
Figure 56: South Asia 3D Bioprinting Market Attractiveness Analysis By End User, 2020-2030
Figure 57: South Asia 3D Bioprinting Market Attractiveness Analysis By Country, 2020-2030
Figure 58: East Asia 3D Bioprinting Market Value Analysis (US$ Mn), 2015-2019
Figure 59: East Asia 3D Bioprinting Market Value Forecast (US$ Mn), 2020-2030 & Y-o-Y Growth (%), 2020-2030
Figure 60: East Asia 3D Bioprinting Market Share, By Technology (2020)
Figure 61: East Asia 3D Bioprinting Market Share, By End User (2020)
Figure 62: East Asia 3D Bioprinting Market Share, By Application (2020)
Figure 63: East Asia 3D Bioprinting Market Share, By Country (2020)
Figure 64: East Asia 3D Bioprinting Market Attractiveness Analysis By Technology, 2020-2030
Figure 65: East Asia 3D Bioprinting Market Attractiveness Analysis By Application, 2020-2030
Figure 66: East Asia 3D Bioprinting Market Attractiveness Analysis By End User, 2020-2030
Figure 67: East Asia 3D Bioprinting Market Attractiveness Analysis By Country, 2020-2030
Figure 68: Oceania 3D Bioprinting Market Value Analysis (US$ Mn), 2015-2019
Figure 69: Oceania 3D Bioprinting Market Value Forecast (US$ Mn), 2020-2030 & Y-o-Y Growth (%), 2020-2030
Figure 70: Oceania 3D Bioprinting Market Share, By Technology (2020)
Figure 71: Oceania 3D Bioprinting Market Share, By End User (2020)
Figure 72: Oceania 3D Bioprinting Market Share, By Application (2020)
Figure 73: Oceania 3D Bioprinting Market Share, By Country (2020)
Figure 74: Oceania 3D Bioprinting Market Attractiveness Analysis By Technology, 2020-2030
Figure 75: Oceania 3D Bioprinting Market Attractiveness Analysis By Application, 2020-2030
Figure 76: Oceania 3D Bioprinting Market Attractiveness Analysis By End User, 2020-2030
Figure 77: Oceania 3D Bioprinting Market Attractiveness Analysis By Country, 2020-2030
Figure 78: Middle East and Africa 3D Bioprinting Market Value Analysis (US$ Mn), 2015-2019
Figure 79: Middle East and Africa 3D Bioprinting Market Value Forecast (US$ Mn), 2020-2030 & Y-o-Y Growth (%), 2020-2030
Figure 80: Middle East and Africa 3D Bioprinting Market Share, By Technology (2020)
Figure 81: Middle East and Africa 3D Bioprinting Market Share, By End User (2020)
Figure 82: Middle East and Africa 3D Bioprinting Market Share, By Application (2020)
Figure 83: Middle East and Africa 3D Bioprinting Market Share, By Country (2020)
Figure 84: Middle East and Africa 3D Bioprinting Market Attractiveness Analysis By Technology, 2020-2030
Figure 85: Middle East and Africa 3D Bioprinting Market Attractiveness Analysis By Application, 2020-2030
Figure 86: Middle East and Africa 3D Bioprinting Market Attractiveness Analysis By End User, 2020-2030
Figure 87: Middle East and Africa 3D Bioprinting Market Attractiveness Analysis By Country, 2020-2030
Figure 88: U.S Market Value Proportion Analysis, 2020
Figure 89: Global Vs. U.S Growth Comparison
Figure 90: U.S. 3D Bioprinting Market Share Analysis (%) By Technology, 2020 & 2030
Figure 91: U.S. 3D Bioprinting Market Share Analysis (%) By Application, 2020 & 2030
Figure 92: U.S. 3D Bioprinting Market Share Analysis (%) By End User, 2020 & 2030
Figure 93: Canada Market Value Proportion Analysis, 2020
Figure 94: Global Vs. Canada Growth Comparison
Figure 95: Canada. 3D Bioprinting Market Share Analysis (%) By Technology, 2020 & 2030
Figure 96: Canada. 3D Bioprinting Market Share Analysis (%) By Application, 2020 & 2030
Figure 97: Canada. 3D Bioprinting Market Share Analysis (%) By End User, 2020 & 2030
Figure 98: Mexico Market Value Proportion Analysis, 2020
Figure 99: Global Vs. Mexico Growth Comparison
Figure 101: Mexico. 3D Bioprinting Market Share Analysis (%) By Technology, 2020 & 2030
Figure 102: Mexico. 3D Bioprinting Market Share Analysis (%) By Application, 2020 & 2030
Figure 103: Mexico. 3D Bioprinting Market Share Analysis (%) By End User, 2020 & 2030
Figure 104: Brazil Market Value Proportion Analysis, 2020
Figure 105: Global Vs. Brazil Growth Comparison
Figure 106: Brazil. 3D Bioprinting Market Share Analysis (%) By Technology, 2020 & 2030
Figure 107: Brazil. 3D Bioprinting Market Share Analysis (%) By Application, 2020 & 2030
Figure 107: Brazil. 3D Bioprinting Market Share Analysis (%) By End User, 2020 & 2030
Figure 108: U.K. Market Value Proportion Analysis, 2020
Figure 109: Global Vs. U.K. Growth Comparison
Figure 110: U.K. 3D Bioprinting Market Share Analysis (%) By Technology, 2020 & 2030
Figure 111: U.K. 3D Bioprinting Market Share Analysis (%) By Application, 2020 & 2030
Figure 112: U.K. 3D Bioprinting Market Share Analysis (%) By End User, 2020 & 2030
Figure 113: Germany Market Value Proportion Analysis, 2020
Figure 114: Global Vs. Germany Growth Comparison
Figure 115: Germany. 3D Bioprinting Market Share Analysis (%) By Technology, 2020 & 2030
Figure 116: Germany. 3D Bioprinting Market Share Analysis (%) By Application, 2020 & 2030
Figure 117: Germany. 3D Bioprinting Market Share Analysis (%) By End User, 2020 & 2030
Figure 118: France Market Value Proportion Analysis, 2020
Figure 119: Global Vs. France Growth Comparison
Figure 120: France. 3D Bioprinting Market Share Analysis (%) By Technology, 2020 & 2030
Figure 121: France. 3D Bioprinting Market Share Analysis (%) By Application, 2020 & 2030
Figure 122: France. 3D Bioprinting Market Share Analysis (%) By End User, 2020 & 2030
Figure 123: Italy Market Value Proportion Analysis, 2020
Figure 124: Global Vs. Italy Growth Comparison
Figure 125: Italy. 3D Bioprinting Market Share Analysis (%) By Technology, 2020 & 2030
Figure 126: Italy. 3D Bioprinting Market Share Analysis (%) By Application, 2020 & 2030
Figure 127: Italy. 3D Bioprinting Market Share Analysis (%) By End User, 2020 & 2030
Figure 128: Spain Market Value Proportion Analysis, 2020
Figure 129: Global Vs. Spain Growth Comparison
Figure 130: Spain. 3D Bioprinting Market Share Analysis (%) By Technology, 2020 & 2030
Figure 131: Spain. 3D Bioprinting Market Share Analysis (%) By Application, 2020 & 2030
Figure 132: Spain. 3D Bioprinting Market Share Analysis (%) By End User, 2020 & 2030
Figure 133: Russia Market Value Proportion Analysis, 2020
Figure 134: Global Vs. Russia Growth Comparison
Figure 135: Russia. 3D Bioprinting Market Share Analysis (%) By Technology, 2020 & 2030
Figure 136: Russia. 3D Bioprinting Market Share Analysis (%) By Application, 2020 & 2030
Figure 137: Russia. 3D Bioprinting Market Share Analysis (%) By End User, 2020 & 2030
Figure 138: China Market Value Proportion Analysis, 2020
Figure 139: Global Vs. China Growth Comparison
Figure 140: China. 3D Bioprinting Market Share Analysis (%) By Technology, 2020 & 2030
Figure 141: China. 3D Bioprinting Market Share Analysis (%) By Application, 2020 & 2030
Figure 142: China. 3D Bioprinting Market Share Analysis (%) By End User, 2020 & 2030
Figure 143: Japan Market Value Proportion Analysis, 2020
Figure 144: Global Vs. Japan Growth Comparison
Figure 145: Japan. 3D Bioprinting Market Share Analysis (%) By Technology, 2020 & 2030
Figure 146: Japan. 3D Bioprinting Market Share Analysis (%) By Application, 2020 & 2030
Figure 147: Japan. 3D Bioprinting Market Share Analysis (%) By End User, 2020 & 2030
Figure 148: South Korea Market Value Proportion Analysis, 2020
Figure 149: Global Vs. South Korea Growth Comparison
Figure 150: South Korea. 3D Bioprinting Market Share Analysis (%) By Technology, 2020 & 2030
Figure 151: South Korea. 3D Bioprinting Market Share Analysis (%) By Application, 2020 & 2030
Figure 152: South Korea. 3D Bioprinting Market Share Analysis (%) By End User, 2020 & 2030
Figure 153: India Market Value Proportion Analysis, 2020
Figure 154: Global Vs. India Growth Comparison
Figure 155: India. 3D Bioprinting Market Share Analysis (%) By Technology, 2020 & 2030
Figure 156: India. 3D Bioprinting Market Share Analysis (%) By Application, 2020 & 2030
Figure 157: India. 3D Bioprinting Market Share Analysis (%) By End User, 2020 & 2030
Figure 158: Indonesia Market Value Proportion Analysis, 2020
Figure 159: Global Vs. Indonesia Growth Comparison
Figure 160: Indonesia. 3D Bioprinting Market Share Analysis (%) By Technology, 2020 & 2030
Figure 161: Indonesia. 3D Bioprinting Market Share Analysis (%) By Application, 2020 & 2030
Figure 162: Indonesia. 3D Bioprinting Market Share Analysis (%) By End User, 2020 & 2030
Figure 163: Australia Market Value Proportion Analysis, 2020
Figure 164: Global Vs. Australia Growth Comparison
Figure 165: Australia. 3D Bioprinting Market Share Analysis (%) By Technology, 2020 & 2030
Figure 166: Australia. 3D Bioprinting Market Share Analysis (%) By Application, 2020 & 2030
Figure 167: Australia. 3D Bioprinting Market Share Analysis (%) By End User, 2020 & 2030
Figure 168: New Zealand Market Value Proportion Analysis, 2020
Figure 169: Global Vs. New Zealand Growth Comparison
Figure 170: New Zealand. 3D Bioprinting Market Share Analysis (%) By Technology, 2020 & 2030
Figure 171: New Zealand. 3D Bioprinting Market Share Analysis (%) By Application, 2020 & 2030
Figure 172: New Zealand. 3D Bioprinting Market Share Analysis (%) By End User, 2020 & 2030
Figure 173: GCC Countries Market Value Proportion Analysis, 2020
Figure 174: Global Vs. GCC Countries Growth Comparison
Figure 175: GCC Countries. 3D Bioprinting Market Share Analysis (%) By Technology, 2020 & 2030
Figure 176: GCC Countries. 3D Bioprinting Market Share Analysis (%) By Application, 2020 & 2030
Figure 177: GCC Countries. 3D Bioprinting Market Share Analysis (%) By End User, 2020 & 2030
Figure 178: South Africa Market Value Proportion Analysis, 2020
Figure 179: Global Vs. South Africa Growth Comparison
Figure 180: South Africa. 3D Bioprinting Market Share Analysis (%) By Technology, 2020 & 2030
Figure 181: South Africa. 3D Bioprinting Market Share Analysis (%) By Application, 2020 & 2030
Figure 182: South Africa. 3D Bioprinting Market Share Analysis (%) By End User, 2020 & 2030
Figure 183: Turkey Market Value Proportion Analysis, 2020
Figure 184: Global Vs. Turkey Growth Comparison
Figure 185: Turkey. 3D Bioprinting Market Share Analysis (%) By Technology, 2020 & 2030
Figure 186: Turkey. 3D Bioprinting Market Share Analysis (%) By Application, 2020 & 2030
Figure 187: Turkey. 3D Bioprinting Market Share Analysis (%) By End User, 2020 & 2030
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
